prednisone has been researched along with osteoprotegerin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koivula, MK; Konttinen, YT; Laasonen, L; Mandelin, J; Risteli, J; Valleala, H | 1 |
| Angelopoulou, MK; Dimopoulou, MN; Gribabis, DA; Kokoris, SI; Kyrtsonis, MC; Pangalis, GA; Siakantaris, MP; Vassilakopoulos, TP | 1 |
| Chen, CF; Chen, XY; Lin, HY; Lin, MF; Liu, CY; Liu, JL; Wang, ZF; Wu, XH; Zheng, J; Zheng, XM | 1 |
| Chen, X; Lin, X; Liu, Y; Wu, X; Ye, M; Zheng, J | 1 |
| Chen, L; Feng, T; Guo, D; Wang, H; Zhang, M; Zhou, Y | 1 |
1 trial(s) available for prednisone and osteoprotegerin
| Article | Year |
|---|---|
Effect of cyclical intermittent etidronate therapy on circulating osteoprotegerin levels in patients with rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Arthrography; Collagen Type I; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Etidronic Acid; Female; Glycoproteins; Humans; Male; Middle Aged; Osteoprotegerin; Peptide Fragments; Peptides; Prednisone; Procollagen; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor | 2003 |
4 other study(ies) available for prednisone and osteoprotegerin
| Article | Year |
|---|---|
Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Biomarkers, Tumor; Bone Resorption; Cyclophosphamide; Dexamethasone; Diphosphonates; Doxorubicin; Female; Fibroblast Growth Factor 2; Follow-Up Studies; Glycoproteins; Humans; Life Tables; Male; Melphalan; Membrane Glycoproteins; Middle Aged; Multiple Myeloma; Neoplasm Proteins; Neoplasm Staging; Neovascularization, Pathologic; Osteoprotegerin; Pamidronate; Prednisone; Prognosis; Proteoglycans; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Survival Analysis; Syndecan-1; Syndecans; Vincristine | 2004 |
[Effect of modified sijunzi decoction on the bone metabolism of adriamycin induced nephropathy rats].
Topics: Acid Phosphatase; Animals; Doxorubicin; Drugs, Chinese Herbal; Isoenzymes; Male; Nephrosis; Osteocalcin; Osteoprotegerin; Prednisone; RANK Ligand; Rats; Rats, Sprague-Dawley; Tartrate-Resistant Acid Phosphatase; Tibia | 2013 |
Prednisone inhibits the focal adhesion kinase/receptor activator of NF-κB ligand/mitogen-activated protein kinase signaling pathway in rats with adriamycin-induced nephropathy.
Topics: Animals; Antibiotics, Antineoplastic; Doxorubicin; Drug Evaluation, Preclinical; Focal Adhesion Kinase 1; Gene Expression; Kidney; Male; MAP Kinase Signaling System; Membrane Proteins; Mitogen-Activated Protein Kinases; Nephritis; Osteoprotegerin; Prednisone; Proteinuria; RANK Ligand; Rats, Sprague-Dawley | 2015 |
Sanggenon C Stimulates Osteoblastic Proliferation and Differentiation, Inhibits Osteoclastic Resorption, and Ameliorates Prednisone-Induced Osteoporosis in Zebrafish Model.
Topics: Alkaline Phosphatase; Animals; Benzofurans; Cell Differentiation; Cell Line; Cell Proliferation; Chromones; Collagen; Core Binding Factor alpha Subunits; Disease Models, Animal; Gene Expression Regulation; Mice; Osteoblasts; Osteoclasts; Osteoporosis; Osteoprotegerin; Prednisone; RANK Ligand; Zebrafish | 2018 |